Welcome to LookChem.com Sign In|Join Free
  • or
(6-CHLORO-IMIDAZO[1,2-A]PYRIDIN-2-YL)-ACETIC ACID is a chemical compound characterized by the molecular formula C9H6ClN3O2. It is a derivative of the heterocyclic imidazo[1,2-a]pyridine, which features a ring structure composed of nitrogen and carbon atoms. The incorporation of a chloro group and an acetic acid functional group endows (6-CHLORO-IMIDAZO[1,2-A]PYRIDIN-2-YL)-ACETIC ACID with unique properties and potential applications in pharmaceutical and agricultural sectors. Its chemical structure suggests that it may possess biological activities relevant for the development of new drugs and could also be explored for use as a pesticide or herbicide. Further research and testing are essential to fully explore and understand the compound's potential utility.

59128-13-1

Post Buying Request

59128-13-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

59128-13-1 Usage

Uses

Used in Pharmaceutical Industry:
(6-CHLORO-IMIDAZO[1,2-A]PYRIDIN-2-YL)-ACETIC ACID is used as a chemical intermediate for the development of new drugs due to its unique chemical structure and potential biological activities. Its presence of heterocyclic rings and functional groups may contribute to the compound's pharmacological properties, making it a promising candidate for further research and development in medicinal chemistry.
Used in Agricultural Industry:
(6-CHLORO-IMIDAZO[1,2-A]PYRIDIN-2-YL)-ACETIC ACID is used as a potential pesticide or herbicide due to its chemical properties. The presence of the chloro and acetic acid groups may provide the compound with pesticidal or herbicidal activities, which could be harnessed for the control of pests and weeds in agriculture. Further testing and optimization would be required to develop (6-CHLORO-IMIDAZO[1,2-A]PYRIDIN-2-YL)-ACETIC ACID into a viable agricultural product.

Check Digit Verification of cas no

The CAS Registry Mumber 59128-13-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,1,2 and 8 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 59128-13:
(7*5)+(6*9)+(5*1)+(4*2)+(3*8)+(2*1)+(1*3)=131
131 % 10 = 1
So 59128-13-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H7ClN2O2/c10-6-1-2-8-11-7(3-9(13)14)5-12(8)4-6/h1-2,4-5H,3H2,(H,13,14)

59128-13-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(6-chloroimidazo[1,2-a]pyridin-2-yl)acetic acid

1.2 Other means of identification

Product number -
Other names chloroimidazoapyridinylaceticacid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:59128-13-1 SDS

59128-13-1Relevant academic research and scientific papers

Compounds for treating spinal muscular atrophy

-

Page/Page column 360, (2017/05/02)

Provided herein are compounds, compositions thereof and uses therewith for treating spinal muscular atrophy. In a specific embodiment, provided herein are compounds of a form that may be used to modulate the inclusion of exon 7 of SMN2 into mRNA that is transcribed from the SMN2 gene. In another specific embodiment, provided herein are compounds of a form that may be used to modulate the inclusion of exon 7 of SMN1 into mRNA that is transcribed from the SMN1 gene. In yet another embodiment, provided herein are compounds of a form that may be used to modulate the inclusion of exon 7 of SMN1 and SMN2 into mRNA that is transcribed from the SMN1 and SMN2 genes, respectively.

COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY

-

Paragraph 00763; 00765, (2013/07/19)

Provided herein are compounds, compositions thereof and uses therewith for treating spinal muscular atrophy. In a specific embodiment, provided herein are compounds of a form that may be used to modulate the inclusion of exon 7 of SMN2 into mRNA that is transcribed from the SMN2 gene. In another specific embodiment, provided herein are compounds of a form that may be used to modulate the inclusion of exon 7 of SMN1 into mRNA that is transcribed from the SMN1 gene. In yet another embodiment, provided herein are compounds of a form that may be used to modulate the inclusion of exon 7 of SMN1 and SMN2 into mRNA that is transcribed from the SMN1 and SMN2 genes, respectively.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 59128-13-1